PetMed Express reports Q2 EPS 0c vs. 13c last year

Reports Q2 revenue $71M vs. $65.4M last year. “We are excited to see the business continue to positively evolve into a recurring revenue business driven by our AutoShip & Save and PetPlus programs, which represented 51% of revenue during the quarter, up from 39% at the same time last year,” said Matt Hulett, CEO and President. “PetMeds is focused on integrating and executing our newly acquired partnerships and assets to provide more value to our customers, which will also help strengthen our positioning in the pet health space, including our core PetMeds medication customer base.”